<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="original author and source are credited. https://www.cureus.com/articles/18250-further-evidence-that-onabotulinum-toxin-is-a-viable-treatment-option-for-pediatric-chronic-migraine-patients Abstract Introduction Chronic" exact="migraine" post="is particularly devastating. It affects school work, extracurricular activities,"/>
 <result pre="the International Classification of Headache Disorders, 3rd edition (ICHD-3), chronic" exact="migraine" post="is defined as 15 or more headache days per"/>
 <result pre="least on eight days per month, there are features of" exact="migraine" post="headache. Although botulinum toxin type A (BoNTA) has been"/>
 <result pre="type A (BoNTA) has been proven effective for treating chronic" exact="migraine" post="in adults, little literature exists about its use in"/>
 <result pre="of 30 adolescent migraineurs who met ICHD-3 criteria for chronic" exact="migraine" post="were treated with BoNTA injection according to the standardized"/>
 <result pre="BoNTA injection was a safe and effective therapy for chronic" exact="migraine" post="in our cohort of children recalcitrant to medical therapy."/>
 <result pre="evaluate the long-term safety and efficacy in this population. chronic" exact="migraine" post="pain management pediatrics children headaches stress social health academic"/>
 <result pre="children headaches stress social health academic performance family relations pediatric" exact="migraine" post="The content published in Cureus is the result of"/>
 <result pre="all age groups. It appears that the typical onset of" exact="migraine" post="is during early to mid-adolescence. It can begin at"/>
 <result pre="any age and, unfortunately for many, this early onset of" exact="migraine" post="often continues into adulthood [ 1- 2]. Migraine headache"/>
 <result pre="shot up to 20% in older adolescents [ 9]. A" exact="migraine" post="headache in children is usually frontotemporal and an occipital"/>
 <result pre="the adult and pediatric populations, overall, the clinical presentation of" exact="migraine" post="is similar, regardless of age, and the pathophysiology is"/>
 <result pre="International Classification of Headache Disorders, 3rd edition (ICHD-3) defines chronic" exact="migraine" post="as 15 or more headache days per month for"/>
 <result pre="at least eight days per month, there are features of" exact="migraine" post="headache. The other days can also be migraine or"/>
 <result pre="features of migraine headache. The other days can also be" exact="migraine" post="or tension-type; however, at least eight days per month"/>
 <result pre="Current literature regarding pediatric headaches uses terminology such as chronic" exact="migraine" post="and chronic daily headache, including both terms in the"/>
 <result pre="5- 6, 11- 13]. For the purpose of clarity, chronic" exact="migraine" post="and chronic tension type headaches are the most frequent"/>
 <result pre="Type A (BoNTA) has been proven effective for treating chronic" exact="migraine" post="in adults, scant literature exists about its use in"/>
 <result pre="to the muscle relaxation effects mentioned above, in particular, with" exact="migraine" post="headaches. In 2014, Burstein et al. were able to"/>
 <result pre="meningeal nociceptors have an important role in the initiation of" exact="migraine" post="headaches [ 17]. Burstein et al. showed that BoNTA"/>
 <result pre="Duke pediatric neurology clinic) who met ICHD-3 criteria for chronic" exact="migraine" post="and were treated with Botox (BoNTA; Allergan, Dublin, Ireland)"/>
 <result pre="that Botox significantly decreased the severity and frequency of chronic" exact="migraine" post="headache [ 18- 19]. The head/neck region is divided"/>
 <result pre="severe range. Figure 1 Pre- and Post-Treatment Severity Discussion Chronic" exact="migraine" post="is a serious problem and can be particularly devastating,"/>
 <result pre="[ 20- 23]. There are no FDA-approved medications for chronic" exact="migraine" post="in the pediatric population. This, along with the fact"/>
 <result pre="trials, shows just how much of a challenge treating chronic" exact="migraine" post="in the pediatric population is. The American Academy of"/>
 <result pre="in producing various guidelines [ 24]. Although the pathomechanism of" exact="migraine" post="is not fully understood, there are treatments that have"/>
 <result pre="in the adult population that are not even specific for" exact="migraine" post="such as antidepressants, antiepileptics, antihistamines, calcium ion channel antagonists,"/>
 <result pre="have a basic understanding of how this toxin works in" exact="migraine" post="as opposed to some of the oral medications. Importantly,"/>
 <result pre="side effects of the use of onabotulinum in the adult" exact="migraine" post="population and among not only our retrospective study but"/>
 <result pre="be interesting to see if there is a certain chronic" exact="migraine" post="profile that would suggest that onabotulinum toxin would be"/>
 <result pre="and if this treatment would be efficacious in patients with" exact="migraine" post="variants. How the pediatric chronic migraine multimodal prevention model"/>
 <result pre="efficacious in patients with migraine variants. How the pediatric chronic" exact="migraine" post="multimodal prevention model will look in the near future"/>
 <result pre="what will the role of cGRP inhibitors be in pediatric" exact="migraine" post="prophylaxis, as it is widely utilized now in the"/>
 <result pre="prophylaxis, as it is widely utilized now in the adult" exact="migraine" post="population. Perhaps there may be an additive effect of"/>
 <result pre="frequently observed in the pediatric population. The shorter duration of" exact="migraine" post="attacks and other semeiological features of migraines in children"/>
 <result pre="BoNTA injection was a safe and effective therapy for chronic" exact="migraine" post="in our cohort of children recalcitrant to medical therapy."/>
 <result pre="studies already published, commenting on different aspects, such as chronic" exact="migraine" post="frequency, intensity, duration, and effect on quality of life,"/>
 <result pre="involve animal subjects or tissue. References References 1 Prevalence of" exact="migraine" post="headache in the United States. Relation to age, income,"/>
 <result pre="117 12 2012 22274570 6 Botulinum toxin injections for chronic" exact="migraine" post="in adolescents - an early therapeutic option in the"/>
 <result pre="82 2014 24446117 7 The epidemiology, burden, and comorbidities of" exact="migraine" post="Neurol Clin Bigal ME Lipton RB 321 334 27"/>
 <result pre="Lipton RB 321 334 27 2009 19289218 8 Epidemiology of" exact="migraine" post="and headache in children and adolescents Curr Pain Headache"/>
 <result pre="Headache Rep Wöber-Bingöl Ç 341 17 2013 23700075 9 Pediatric" exact="migraine" post="Neurol Clin Lewis D 481 501 27 2009 19289227"/>
 <result pre="481 501 27 2009 19289227 10 Similarities and differences between" exact="migraine" post="in children and adults: presentation, disability, and response to"/>
 <result pre="Powers SW 48 21 2017 29071512 11 Botox treatment for" exact="migraine" post="and chronic daily headache in adolescents J Neurosci Nurs"/>
 <result pre="meningeal nociceptors by botulinum neurotoxin type A: therapeutic implications for" exact="migraine" post="and other pains Cephalalgia Burstein R Zhang X Levy"/>
 <result pre="KR Weisman SJ 991 1002 36 2011 21 Impact of" exact="migraine" post="on the family: perspectives of people with migraine and"/>
 <result pre="Impact of migraine on the family: perspectives of people with" exact="migraine" post="and their spouse/domestic partner in the CaMEO study Mayo"/>
 <result pre="Adams AM Lipton RB 596 611 91 2016 22 Chronic" exact="migraine" post="prevalence, disability, and sociodemographic factors: results from the American"/>
 <result pre="Lipton RB 1456 1470 52 2012 22830411 23 Impact of" exact="migraine" post="on the family Headache Smith R 423 426 38"/>
 <result pre="205 11 2010 25 Preventive drugs in childhood and adolescent" exact="migraine" post="Curr Pain Headache Rep Kacperski J Hershey AD 422"/>
 <result pre="AD 422 18 2014 24760491 26 Prophylactic drug treatment of" exact="migraine" post="in children and adolescents: an update Curr Pain Headache"/>
</results>
